---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
webUrl: "https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered"
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: "https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg"
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "hVhnPfaPsDeJoWnMCS84vYds4RTmaNotuQjIX3PiRjy3j8qvHu9WJgAk++LM9uavLlWL8gixrr4/T3BRyH5DLNXIWncacH3R9XaU7PymagaE91qNPGuQoVzd0QzmNEzR7vmd/6ymEO6NEGC7csfTv5uE4IEV3AJ5DJzwpQ5n51Z4f3bj06595lcYLIidOe6IELxf1V5wQjerQ874oOHXoVRrfE1EwnZZMdE3JCyCipopMTvhV58tiO99AizG6r8wH0a47+vTyuJg9dGkhPgRFgPrIrHzWlLAFHfig8MCMkhgoEeIGAZ9m2C9IMD8Gjuj;7mLXf/sbrZeU09bDojwWZw=="
---

